Physician profile
William Rush Cook
NPI 1699700930
$1,540.13
in general payments reported to CMS, 2019-2025
23 companies · $31.01 in 2025
The $31.01 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $241 · 2021: $341 · 2022: $425 · 2023: $180 · 2024: $6.69 · 2025: $31.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $217.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $267.72 | 2019-2022 | |
| Abbott Laboratories | $229.37 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $125.76 | 2019-2023 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $94.89 | 2019-2023 | Lifevest |
| Amgen INC. | $90.23 | 2020-2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $87.58 | 2019-2023 | Leqvio |
| Boston Scientific Corporation | $86.73 | 2019-2023 | |
| Biotronik INC. | $84.27 | 2019-2023 | Rivacor 7 Dr-T |
| Merck Sharp & Dohme LLC | $79.18 | 2021-2023 | Verquvo |
| Cvrx, INC. | $45.98 | 2021-2024 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $42.56 | 2019-2022 | |
| Pfizer INC. | $40.86 | 2020-2022 | |
| Alnylam Pharmaceuticals INC. | $40.07 | 2022 | |
| Philips North America LLC | $34.70 | 2020 | |
| Kestra Medical Technology Services, INC. | $33.43 | 2023 | Assure Wcd |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.85 | 2021-2022 | |
| Atricure, INC. | $31.01 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Medtronic Vascular, INC. | $25.44 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $22.03 | 2022 | |
| Astellas Pharma US INC | $15.20 | 2019 | |
| Novo Nordisk INC | $14.47 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.80 | 2019 | |
| Bardy Diagnostics, INC. | $5.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.